Form 4: Aerovate Therapeutics Director David S. Grayzel Reports Sale of Shares

Director David S. Grayzel reported the sale of 11,882 shares of Aerovate Therapeutics, Inc. common stock at an average price of $28.15 on April 9, 2024.

Summary

• On April 9, 2024, David S. Grayzel, a director of Aerovate Therapeutics, Inc., sold 11,882 shares of common stock at a weighted average price of $28.15.
• The sales occurred in multiple transactions with prices ranging from $28.00 to $28.34.
• Following the reported transaction, Grayzel indirectly owns 14,502 shares through Atlas Venture Associates XII, L.P. and 1,784,730 shares through Atlas Venture Fund XII, L.P.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. Insider sales can sometimes be perceived negatively, but without further context, it's a routine disclosure.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell the company's stock. These filings are closely watched by investors as they can provide insights into management's perspective on the company's valuation and future prospects.

Comparison to Industry Standards

• Insider sales are a common occurrence in publicly traded companies.
• It's important to consider the context of the sale, such as the size of the sale relative to the insider's total holdings, and whether other insiders are also selling shares.
• Without additional context, it's difficult to compare this specific transaction to industry standards, but similar transactions can be observed in companies like United Therapeutics (UTHR) and Acceleron Pharma (acquired by Merck), which operate in related therapeutic areas.

Stakeholder Impact

• The sale of shares by a director could potentially create uncertainty among shareholders.
• However, the impact is likely minimal given the relatively small number of shares sold compared to the total outstanding shares and the indirect holdings of the reporting person.

Key Dates